University of Lethbridge   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Lethbridge Canada (1967)

Organization Overview

First Clinical Trial
2011
NCT01277445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

University of Lethbridge

Active Ingredients

Drugs in Phase 2 Trials (1)

amino acids (Freamine) (1 trial)

Drugs in Phase 1 Trials (1)

naltrexone (revia) (1 trial)

Drugs in Other Trials (1)

inulin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gambling (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3